SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-026538
Filing Date
2019-05-15
Accepted
2019-05-15 16:03:48
Documents
51
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv521342_10q.htm 10-Q 477878
2 EXHIBIT 10.1 tv521342_ex10-1.htm EX-10.1 129072
3 EXHIBIT 10.2 tv521342_ex10-2.htm EX-10.2 29090
4 EXHIBIT 10.3 tv521342_ex10-3.htm EX-10.3 51748
5 EXHIBIT 31.1 tv521342_ex31-1.htm EX-31.1 9632
6 EXHIBIT 32.1 tv521342_ex32-1.htm EX-32.1 5214
  Complete submission text file 0001144204-19-026538.txt   4100110

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rgrx-20190331.xml EX-101.INS 980808
8 XBRL TAXONOMY EXTENSION SCHEMA rgrx-20190331.xsd EX-101.SCH 33225
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgrx-20190331_cal.xml EX-101.CAL 30376
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgrx-20190331_def.xml EX-101.DEF 179898
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgrx-20190331_lab.xml EX-101.LAB 244623
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgrx-20190331_pre.xml EX-101.PRE 221919
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15070 | Film No.: 19827926
SIC: 2834 Pharmaceutical Preparations